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Abstract— Clinical research studies in Parkinson’s Disease 
(PD) focusing on symptom assessment often rely on thorough 
time-consuming physical examinations quantified on clinical 
scales such as the Unified Parkinson’s Disease Rating Scale 
(UPDRS). Although widely used in clinical research, realistic 
time constraints preclude its use in daily clinical practice. The 
Hoehn and Yahr (H&Y) staging is an alternative scale which is 
easier to administer and provides a succinct descriptor of overall 
PD severity. There is no universal agreement amongst 
neurologists on the specific PD symptoms they need to be 
assessing in order to prescribe treatments and optimize 
symptom management for their patients, and practically there 
are no clinical scales which are recorded in daily clinical 
practice. In this study, we systematically evaluate diverse 
symptoms (as expressed in 44 UPDRS items) and aim to provide 
a statistical association with UPDRS and H&Y using rank 
correlation and mutual information metrics. Moreover, we 
investigate the projection of a UPDRS item subset on a 2D plot 
to map onto H&Y. We report some statistically strong 
correlations of PD symptoms against UPDRS and H&Y 
(|𝑹| ≥ 𝟎. 𝟑), and provide an intuitively appealing visualization 
mapping onto H&Y. These findings may be useful to 
neurologists as practical guidance in their daily clinical routine. 
I. INTRODUCTION 
Parkinson’s Disease (PD) is a chronic neurodegenerative 
disorder characterized by the manifestation of a range or motor 
symptoms and non-motor symptoms [1]. Disease onset is 
likely a combination of dopaminergic neuron reduction in the 
basal ganglia and degeneration of non-dopaminergic pathways 
[1]. Medication and surgical intervention can alleviate most of 
the symptoms and improve quality of life for most People With 
Parkinson’s (PWP) [2]. To optimize treatment frequent 
physical assessment by expert neurologists is required, 
however, in practice PWP are typically followed up by expert 
clinicians at intervals often spanning 6 or 12 months, which 
may underestimate symptom severity progression. 
Standardized clinical scales have been proposed to 
quantify PD symptom severity. The Unified Parkinson’s 
Disease Rating Scale (UPDRS) [3] is the most widely used 
scale in clinical research studies [4], quantifying the 
constellation of multiple motor, non-motor PD symptoms, 
and complications of therapy. It consists of 44 items, where 
each item spans the range 0 (symptom-free) to 4 (severe 
disability). It is organized around four major components, 
each composed of a number of items: (1) Mentation, behavior 
and mood (4 items, items 1-4); (2) Activities of Daily Living 
(ADL, 13 items, items 5-17), assessing whether PWP can 
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complete daily tasks unassisted; (3) Motor (27 items, items 
18-44), addressing muscular control; and (4) Complication of 
therapy (11 items, items 45-55), which expresses dyskinesia 
and disability problems associated with PD treatment. The 
third component is commonly referred to as motor UPDRS, 
and is highly correlated with the total UPDRS [5,6]. For 
untreated PWP the fourth component is not used. The total 
UPDRS is computed by summing up all 44 items (range: 0-
176) and the motor UPDRS by summing up items 18-44 
(range: 0-108). 
Although UPDRS is the gold standard in PD research 
studies, in clinical practice it is rather seldomly used due to 
pragmatic time-constraints. Clinicians anecdotally use subsets 
of UPDRS, focusing on specific items that in their opinion are 
best suited to assess symptoms, and often only the motor 
UPDRS component is administered. Currently, there is no 
uniquely defined subset of items or agreement amongst expert 
neurologists on the most suitable time-efficient approach to 
assess PD symptom severity in daily clinical practice.  
Alternative clinical scales have also been proposed, mainly 
to provide succinct, rudimentary descriptors of overall PD 
symptom severity. Hoehn and Yahr (H&Y) staging [7] is 
particularly practical and especially the modified H&Y is 
commonly used in many clinical centres [8]. The modified 
H&Y is an ordinal scale of eight possible stages: 0, 1, 1.5, 2, 
2.5, 3, 4, 5, where increasing stage progressively quantifies 
more debilitating PD symptoms, providing a simple, general 
clinical impression of PD which requires a less thorough 
physical examination than UPDRS. 
The motivation of this study is to elucidate the use of 
empirical practical tests used in clinical settings for PD 
assessment with the two most commonly used clinical PD 
research scales, UPDRS and H&Y staging. This study’s 
findings provide insight into (a) the statistical association of 
empirical practical tests which may be used as a proxy for 
assessing overall symptom severity (b) the statistical 
association of UPDRS and H&Y, and (c) the UPDRS items 
which may be most predictive of the clinical scales. We 
envisage these findings may be useful to PD neurologists 
facilitating their daily routine assessments in overall PD 
overview assessment using a subset of UPDRS items.  
II. DATA 
The database source of this study is the Parkinson’s 
Disease Data and Organizing Center (PD-DOC) [9] which was 
developed to facilitate the planning, study design, and 
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statistical analysis of PD-related data. The cohort is comprised 
of 566 PWP (1623 samples because some PWP had more than 
one evaluation), collected by several independent clinical 
centers, organized by the University of Rochester. Ethical 
approval was obtained by the IRBs of the participating centers. 
After removing samples containing missing UPDRS and H&Y 
entries, we processed 1594 samples from 562 PWP (363 
males). The participants’ age was (median±interquartile 
range): 63±14 years, with total UPDRS score 28±20, and 
H&Y stage 2±0. For further details see [9]. 
III. METHODS 
A.  Statistical analysis 
We use rank correlation analysis to quantify the association 
strength of UPDRS items with the modified H&Y stages. We 
assess statistical significance (at 𝑝 = 0.01 level) of the null 
hypothesis that UPDRS items have no correlation with total 
UPDRS or H&Y staging. The strength of this association is 
expressed by the magnitude of the correlation coefficient R. 
We followed the standard empirical rule for clinical 
applications to denote relationships as statistically strong 
when the magnitude of the correlation coefficient is equal or 
above 0.3 [10]. We also computed the Mutual Information 
(MI) [11] which quantifies the statistical dependence of H&Y 
on the UPDRS items (MI can account for general nonlinear 
relationships between variables). We report the normalized MI 
on the scale 0 to 1, with 0 indicating no statistical dependence 
between random variables, using our implementation [6]. 
B. Data projection and visualization in 2D embedded space 
Clinical questionnaires and clinical scales often exhibit 
some underlying hidden structure: the rationale is that they 
capture some intrinsic characteristics which are not directly 
observed or quantified. This might be usefully presented in the 
embedded space, where visualization might lead to new 
insights. A widely used approach to project data in 2D is t-
distributed Stochastic Neighbor Embedding (t-SNE) [12]. 
Here, we used t-SNE to visualize how UPDRS items can be 
projected in the 2D space mapped onto H&Y. 
IV. RESULTS 
Figures (1) and (2) present scatter plots to visualize the 
statistical relationships of UPDRS items with UPDRS and 
H&Y. The statistical associations between UPDRS items and 
total UPDRS are summarized in Table I, and between UPDRS 
items and H&Y are summarized in Table II. In all cases, the 
relationships are statistically significant (𝑝 < 0.001). These 
findings suggest that bradykinesia (item 44) followed by ADL 
items (dressing and eating food) are the most statistically 
strongly associated symptoms towards estimating total 
UPDRS. Similarly, item 43 (postural stability) is, statistically, 
the most important UPDRS item in determining H&Y, 
followed by items 42 (gait), 40 (arise from chair), and 44 
(bradykinesia), which is in broad agreement with clinical 
expectations. Interestingly, the postural stability item exhibits 
markedly larger association strength compared to the other 
UPDRS items in terms of H&Y association. Finally, Fig. 3 
presents the projection of the 10 UPDRS items from Table II 
onto H&Y: this plot visually indicates that a subset of UPDRS 
items may provide an overall differentiation of the different 
H&Y stages, particularly for H&Y stages 4 and 5 (marking 
substantial symptom severity). 
V. DISCUSSION 
This study provided a systematic investigation into widely 
used empirical practical tests that clinicians use in their 
routine PD assessment to estimate their statistical association 
with total UPDRS and the modified H&Y staging. We used 
the standard quantification through UPDRS items as a 
convenient means of expressing symptom severity. In a 
previous study we optimized a parametric functional mapping 
of motor UPDRS onto H&Y [13], when all motor UPDRS 
items are available. Here, we tackled a more generic question 
attempting to provide overall assessment of PD symptom 
severity (quantified using total UPDRS and H&Y) without 
the need of recording the full span of the UPDRS items. This 
is a particularly pertinent question, given that typical physical 
examinations of PD patients anecdotally last about 20 minutes 
whereas the total UPDRS assessment administration requires 
longer (depending on the expert rater’s experience). 
TABLE I. ASSOCIATION STRENGTH (NORMALIZED MUTUAL 
INFORMATION & RANK CORRELATIONS) OF ITEMS WITH TOTAL UPDRS 
All data (n = 1594 samples) 
UPDRS item MI Spearman 
correlation 
(44) Bradykinesia 0.089 0.621 
(10) Dressing 0.077 0.60 
(9) Eating food 0.074 0.581 
(19) Face expression 0.073 0.568 
(35) Hand move LH 0.071 0.583 
(11) Hygiene 0.067 0.539 
(18) Speech expression 0.067 0.558 
(27) Rigid neck 0.066 0.533 
(34) Hand move RH 0.066 0.559 
(36) RAM RH 0.065 0.556 
All reported UPDRS items were statistically significantly correlated 
with the total UPDRS (𝑝 < 0.001). For clarity, only the 10 UPDRS 
items most strongly associated with UPDRS are presented here. We 
report the normalized mutual information (MI, range 0-1). LH stands 
for ‘left hand’, ‘RH’ for right hand, and RAM for ‘rapid alternating 
movement’. The numbers in parenthesis refer to the UPDRS item order. 
 
TABLE II. ASSOCIATION STRENGTH (NORMALIZED MUTUAL 
INFORMATION & RANK CORRELATIONS) OF UPDRS ITEMS WITH H&Y 
All data (n = 1594 samples) 
UPDRS item MI Spearman 
correlation 
(43) Postural stability 0.334 0.614 
(42) Gait 0.157 0.403 
(40) Arise from chair 0.135 0.379 
(44) Bradykinesia 0.132 0.413 
(15) Walking 0.120 0.338 
(41) Posture 0.104 0.388 
(12) Turn bed 0.086 0.337 
(10) Dressing 0.084 0.334 
(19) Face expression 0.084 0.342 
(11) Hygiene 0.083 0.290 
All reported UPDRS items were statistically significantly correlated 
with the modified H&Y stages (𝑝 < 0.001). For clarity, only the 10 
UPDRS items most strongly associated with H&Y are presented here. 
We report the normalized mutual information (MI, range 0-1). The 
numbers in parenthesis refer to the UPDRS item order. 
 
  
 
 
 
Fig. 1. Scatter plots of the most strongly associated UPDRS items 
with motor UPDRS (top), and total UPDRS (bottom). The robust 
regression line indicates the trend in the data [6], and we have added 
15% jitter on the UPDRS items to visualize better the number of 
overlapping points. LH stands for ‘left hand’, ‘RH’ for ‘right hand’, 
LUE for ‘left upper extremity’, LLE for left lower extremity’, and 
LL for ‘left leg’. 
 
Fig.2 Scatter plots of the most strongly associated UPDRS items 
with modified H&Y. The robust regression line indicates the trend 
in the data [6], and we have added 15% jitter on the UPDRS items 
to visualize better the number of overlapping points. 
 
The findings in Table I provide very clear guidance on the 
UPDRS item which are univariately most strongly associated 
with the total UPDRS. We computed very strong statistical 
relationships (|𝑅| ≥ 0.3) across multiple items. We remark 
that some are part of motor UPDRS (bradykinesia, face 
expression and speech expression), whilst there are some 
items from the activities of daily living component (dressing, 
eating food, and hygiene). These insights serve well to 
highlight the kind of symptoms clinicians may want to place 
more emphasis on when doing their routine assessments. 
The results of the statistical analysis in Table II suggest that 
UPDRS items 40 (posture), 42 (gait), 43 (postural stability) 
and 44 (bradykinesia) are most strongly correlated with H&Y 
stages. This finding is broad agreement with the revised 
optimized parametric formula we had proposed [13] which 
built on expert neurologists’ clinical intuition [14]. We 
remark that the UPDRS items most strongly associated with 
H&Y are indeed those from the motor component (items 18-
44). Interestingly, item 15 (walking, part of the activities of 
daily living component) is one of the very few items that does 
not form part of the motor UPDRS component and yet is quite 
strongly associated with H&Y. However, this item can also 
be interpreted as referring to a motor symptom nonetheless. 
Overall, these results support the commonly-held notion that 
H&Y is predominantly sensitive to motor symptoms. 
  
 
Fig.3. Projection of the 10 UPDRS items from Table II using t-
SNE to visually assess the relationship with H&Y. 
Fig. 3 projects the multi-dimensional UPDRS feature space 
in a visually appealing 2D plot. In a similar study, we 
previously investigated the constellation of samples for 
different symptom severity categories extracted through 
clustering [15]; here we directly visually assess the overall 
differentiation of the H&Y stages in the projected 2D space. 
Stebbins and Goetz [16] used factor analysis to determine 
the motor UPDRS structure. They reported motor UPDRS can 
be assessed on six distinct factors: speech, facial expression, 
balance and gait (factor I), rest tremor (factor II), rigidity 
(factor IV), right and left bradykinesia (factors III and V), and 
postural tremor (factor VI). We had previously reported 
generally good agreement on a different dataset [6]. However, 
standard factor analysis does not offer a unique representation 
of the data and makes some strong underlying assumptions 
[17]. Future work could investigate the UPDRS latent 
variable structure using sparse principal component analysis 
which has provided interesting insights in a related study [18]. 
Determining the latent variables of UPDRS or ideally a sparse 
setting with few UPDRS items could subsequently facilitate 
analysis e.g. to assess PD symptom severity [5] and for early 
PD biomarkers [19], thus helping scale up research work 
when the entire UPDRS is not fully administered in standard 
clinical practice. This is very well aligned with our recent 
work aiming to develop tools that can be deployed at large 
scale in community studies [20].  
ACKNOWLEDGMENT 
The data source for this work was the Parkinson’s Disease Data 
and Organizing Center (PD-DOC; U01NS050095, PI: Roger 
Kurlan), currently managed by the National Institute of Neurological 
Disorders and Stroke (NINDS). Data has been contributed to the PD-
DOC by the NINDS Udall Centers of Excellence for Parkinson’s 
Disease Research, the NINDS Neuroprotective Exploratory Trials in 
Parkinson’s Disease Program and the Parkinson Study Group. We 
used data from two studies available in the original PD-DOC 
repository: (1) the study from three Udall Centers (PIs: (i) T.M. 
Dawson, (ii) M.K. Lee, (iii) V.L. Dawson), and (2) the PostCEPT 
study (PIs: B. Ravina and A.E. Lang). 
REFERENCES 
[1] C.W. Olanow, M.B. Stern, K. Sethi, “The scientific and clinical basis 
for the treatment of Parkinson disease”, Neurology, Vol. 72, pp. s1-
s136, 2009 
[2] Singh, N, Pillay, V, Choonara E: “Advances in the treatment of 
Parkinson’s disease”, Progress in Neurobiology 2007; 81:29-44 
[3] Fahn S, Elton RL, Members of the UPDRS Development Committee. 
Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, 
Goldstein M, et al, eds. Recent developments in Parkinson’s disease. 
Vol II. New Jersey: Macmillan Healthcare Information, 1987:153–63. 
[4] Ramaker, C, Marinus, J, Stiggelbout AM, van Hilten BJ. Systematic 
evaluation of rating scales for impairment and disability in Parkinson’s 
disease, Movement Disorders 2002; 17:867-876 
[5] A. Tsanas, M.A. Little, P.E. McSharry, L.O. Ramig: “Nonlinear speech 
analysis algorithms mapped to a standard metric achieve clinically 
useful quantification of average Parkinson’s disease symptom 
severity”, Journal Royal Society Interface 2011; 8:842-855 
[6] A. Tsanas, “Accurate telemonitoring of Parkinson’s disease symptom 
severity using nonlinear speech signal processing and statistical 
machine learning”, PhD thesis, Oxford Centre for Industrial and 
Applied Mathematics, University of Oxford, 2012 
[7] Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality, 
Neurology 1967; 17(5):427–42 
[8] Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, 
et al. Movement Disorder Society Task Force report on the Hoehn and 
Yahr staging scale: status and recommendations, Movement Disorders 
2004; 19(9):1020–8 
[9] R. Kurlan R, D. Murphy: “Parkinson’s disease data and organizing 
center”, Movement Disorders 2007; 22:904–5 
[10] A. Tsanas, M.A. Little, P.E. McSharry: “A methodology for the 
analysis of medical data”, in Handbook of Systems and Complexity in 
Health, Eds. J.P. Sturmberg, and C.M. Martin, Springer, pp. 113-125 
(chapter 7), 2013 
[11] T.M. Cover, J.A. Thomas, Elements of information theory, 2nd ed., 
Wiley, ISBN: 978-0-471-24195-9, 2006 
[12] L.J.P. van der Maaten, G.E. Hinton, “Visualizing data using t-
SNE”, Journal of Machine Learning Research 2008; 9:2579–2605 
[13] A. Tsanas, M.A. Little, P.E. McSharry, B.K. Scanlon, S. 
Papapetropoulos: “Statistical analysis and mapping of the Unified 
Parkinson’s Disease Rating Scale to Hoehn and Yahr staging”, 
Parkinsonism and Related Disorders 2012; 18 (5):697-699 
[14] B.K. Scanlon, H.L Katzen, B.E. Levin, C. Singer, S. Papapetropoulos, 
“A revised formula for the conversion of UPDRS-III scores to Hoehn 
and Yahr stage”, Parkinsonism and Related Disorders 2010; 16: 151-2 
[15] B. Sheaves, K. Porcheret, A. Tsanas, C. Espie, R. Foster, D. Freeman, 
P.J. Harrison, K. Wulff, G.M. Goodwin: “Insomnia, nightmares, and 
chronotype as markers of risk for severe mental illness: results from a 
student population”, Sleep 2016; 39(1):173-181 
[16] G. Stebbins, C. Goetz, “Factor Structure of the Unified Parkinson’s 
Disease Rating Scale: Motor Examination Section”, Movement 
Disorders, 1998; 13:633-636 
[17] T. Hastie, R. Tibshirani, J. Friedman, The elements of statistical 
learning: data mining, inference, and prediction, 2nd edition, Springer, 
New York, USA, 2009 
[18] A. Tsanas, K.E.A. Saunders, A.C. Bilderbeck, N. Palmius, G.M. 
Goodwin, M. De Vos: “Clinical insight into latent variables of 
psychiatric questionnaires for mood symptom self-assessment”, JMIR 
Mental Health, 2017; 4(2):e15 
[19] S. Arora, N.P. Visanji, T.A. Mestre, A. Tsanas, A. Al Dakheel, B.S. 
Connolly, C. Gasca-Salas, D.S. Kern, J. Jain, E.J. Slow, A. Faust-
Socher, A.E. Lang, M.A. Little, C. Marras: “Investigating voice as a 
biomarker for leucine-rich repeat kinase 2-associated Parkinson’s 
disease: a pilot study”, Journal of Parkinson’s Disease 2018; 8:503-510 
[20] S. Arora, L. Baghai-Ravary, A. Tsanas: “Developing a large scale 
population screening tool for the assessment of Parkinson’s disease 
using telephone-quality speech”, Journal of Acoustical Society of 
America, in press 
